<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): DECEMBER 21, 2000
INHALE THERAPEUTIC SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE
(State or other jurisdiction of incorporation)
000-23556 94-3134940
(Commission File No.) (IRS Employer Identification No.)
150 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
(Address of principal executive offices and zip code)
Registrant's telephone number, including area code: (650) 631-3100
----------
<PAGE>
ITEM 5. OTHER EVENTS
On December 21, 2000, Inhale Therapeutic Systems, Inc. ("Inhale")
announced an offer to acquire Bradford Particle Design plc, a biotechnology
company registered in England and Wales.
Inhale's press release, dated December 21, 2000, titled "Inhale Announces Offer
to Acquire Bradford Particle Design" is attached hereto as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(C) EXHIBITS
<TABLE>
<CAPTION>
Exhibit Number Description
-------------- ------------------------------------------
<S> <C>
99.1 Press Release titled "Inhale Announces Offer to Acquire
Bradford Particle Design" dated December 21, 2000.
</TABLE>
2.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
INHALE THERAPEUTICS, INC.
Dated: December 21, 2000 By: /s/ Brigid A. Makes
---------------------------------------
Brigid A. Makes
Chief Financial Officer and Vice President
of Finance and Administration
(Principal Financial and Accounting
Officer)
3.
